Benzinga | Aug 6, 2020 06:25AM EDT

Amneal Pharmaceuticals Q2 Adj. EPS $0.13 Beats $0.10 Estimate, Sales $465.00M Beat $458.44M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 30 percent. This is a 44.44 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $465.00 million which beat the analyst consensus estimate of $458.44 million by 1.43 percent. This is a 14.92 percent increase over sales of $404.64 million the same period last year.